U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07273513) titled '"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients' on Nov. 27.
Brief Summary: This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-revascularization patients. A randomized controlled trial design will be used, involving approximately 10-20 hospitals and 951 participants. Eligible participants are adults aged between 18 and 80 years, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.
Study Start Date: ...